Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Genet ; 63(1): 103633, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30797056

ABSTRACT

Potocki-Shaffer syndrome (PSS) is a rare contiguous gene deletion syndrome caused by heterozygous deletion of 11p11.2p12. Typical features described in patients with PSS include developmental delay, intellectual disability, multiple cartilaginous exostoses, biparietal foramina, craniofacial abnormalities, and genitourinary anomalies. While hypertension has been noted in three patients with PSS, it has not been described in most patients with this syndrome. This report details the evaluation and treatment of a teenager with PSS who presented on several occasions during childhood with elevated blood pressure measurements. The renin level was elevated, likely indicating a secondary cause for the HTN. The patient's BP responded to monotherapy with Angiotensin Converting Enzyme Inhibitor (ACEI).


Subject(s)
Chromosome Disorders/genetics , Developmental Disabilities/genetics , Exostoses, Multiple Hereditary/genetics , Exostoses/genetics , Hypertension/genetics , Adolescent , Chromosome Deletion , Chromosome Disorders/blood , Chromosome Disorders/complications , Chromosome Disorders/pathology , Chromosomes, Human, Pair 11/genetics , Developmental Disabilities/blood , Developmental Disabilities/complications , Developmental Disabilities/pathology , Exostoses/blood , Exostoses/complications , Exostoses/pathology , Exostoses, Multiple Hereditary/blood , Exostoses, Multiple Hereditary/complications , Exostoses, Multiple Hereditary/pathology , Female , Heterozygote , Humans , Hypertension/blood , Hypertension/complications , Hypertension/pathology , Phenotype , Renin/blood , Sequence Deletion/genetics
2.
Am J Med Genet A ; 179(10): 1982-1986, 2019 10.
Article in English | MEDLINE | ID: mdl-31342617

ABSTRACT

Potocki-Lupski syndrome (PTLS; MIM 610883) is a neurodevelopmental disorder caused by a microduplication, a 3.7 Mb copy number variant, mapping within chromosome 17p11.2, encompassing the dosage-sensitive RAI1 gene. Whereas RAI1 triplosensitivity causes PTLS, haploinsufficiency of RAI1 due to 17p11.2 microdeletion causes the clinically distinct Smith-Magenis syndrome (SMS; MIM 182290). Most individuals with SMS have an inversion of the melatonin cycle. Subjects with PTLS have mild sleep disturbances such as sleep apnea with no melatonin abnormalities described. Sleep patterns and potential disturbances in subjects with PTLS have not been objectively characterized. We delineated sleep characteristics in 23 subjects with PTLS who underwent a polysomnogram at Texas Children's Hospital. Eleven of these subjects (58%) completed the Child's Sleep Habits Questionnaire (CSHQ). Urinary melatonin was measured in one patient and published previously. While the circadian rhythm of melatonin in PTLS appears not to be disrupted, we identified significant differences in sleep efficiency, percentage of rapid eye movement sleep, oxygen nadir, obstructive apnea hypopnea index, and periodic limb movements between prepubertal subjects with PTLS and previously published normative data. Data from the CSHQ indicate that 64% (7/11) of parents do not identify a sleep disturbance in their children. Our data indicate that younger individuals, <10 years, with PTLS have statistically significant abnormalities in five components of sleep despite lack of recognition of substantial sleep disturbances by parents. Our data support the contention that patients with PTLS should undergo clinical evaluations for sleep disordered breathing and periodic limb movement disorder, both of which are treatable conditions.


Subject(s)
Chromosome Disorders/complications , Sleep Wake Disorders/complications , Abnormalities, Multiple , Adolescent , Child , Chromosome Duplication , Female , Humans , Male , Surveys and Questionnaires
3.
Am J Med Genet A ; 173(3): 716-720, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28127865

ABSTRACT

Potocki-Shaffer syndrome is a contiguous gene deletion syndrome involving 11p11.2p12 and characterized by multiple exostoses, biparietal foramina, genitourinary anomalies in males, central nervous system abnormalities, intellectual disability, and craniofacial abnormalities. Current literature implicates haploinsufficiency of three genes (ALX4, EXT2, and PHF21A) in causing some of the cardinal features of PSS. We report a patient with multiple exostoses, biparietal foramina, and history of mild developmental delay. Cognitive and behavioral testing supported formal diagnoses of anxiety, verbal dyspraxia, articulation disorder, and coordination disorder, without intellectual disability. His facial features, though distinctive, were not typical of those observed in PSS. As the chromosomal deletion does not encompass PHF21A, this case lends further support that haploinsufficiency of PHF21A contributes to the intellectual disability and craniofacial abnormalities in PSS and that there are other genes in the region which likely contribute to the behavioral phenotype in this syndrome. © 2017 Wiley Periodicals, Inc.


Subject(s)
Chromosome Disorders/diagnosis , Chromosome Disorders/genetics , Cognition , Exostoses, Multiple Hereditary/diagnosis , Exostoses, Multiple Hereditary/genetics , Histone Deacetylases/genetics , Phenotype , Child, Preschool , Chromosome Banding , Chromosome Deletion , Chromosome Mapping , Chromosomes, Human, Pair 11/genetics , Comparative Genomic Hybridization , Gene Deletion , Genetic Association Studies , Haploinsufficiency , Humans , Male , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...